Thryv Therapeutics: Funding, Investors & Team (Sep 2026)
Thryv Therapeutics Inc., formerly known as LQT Therapeutics Inc., is a privately owned company located in Montreal, Quebec, Canada. Since 2019, they have been leading the way in precision medicine for treating Long QT Syndrome through SGK1 inhibition and have expanded their focus to include resistant and rare cancer treatments. The development of SGK1 inhibitors presents a new and innovative approach to targeting treatment-resistant cancers, while also complementing existing therapies. This strategic shift has resulted in an additional $15 million in financing, which will support Thryv in completing a proof-of-concept study for LQTS and submitting an IND for resistant cancer treatment.
Thryv Therapeutics has raised $5.0M across 2 funding rounds on record, the most recent an undisclosed round announced in Sep 2025.
Thryv Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2025.
Thryv Therapeutics Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Thryv Therapeutics raised $5.0M in an undisclosed round announced in Jun 2023.
2.3 years later, an undisclosed round was announced in Sep 2025 with no disclosed amount.
Thryv Therapeutics Founders and Leadership Team
Contact details for the Thryv Therapeutics team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Thryv Therapeutics Funding Compared to Other Biotechnology Startups
Funded Startups Like Thryv Therapeutics in Biotechnology and Laval
Companies Similar to Thryv Therapeutics
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Thryv Therapeutics Funding FAQs
What does Thryv Therapeutics do?
Thryv Therapeutics Inc., formerly known as LQT Therapeutics Inc., is a privately owned company located in Montreal, Quebec, Canada. Since 2019, they have been leading the way in precision medicine for treating Long QT Syndrome through SGK1 inhibition and have expanded their focus to include resistant and rare cancer treatments. The development of SGK1 inhibitors presents a new and innovative approach to targeting treatment-resistant cancers, while also complementing existing therapies. This strategic shift has resulted in an additional $15 million in financing, which will support Thryv in completing a proof-of-concept study for LQTS and submitting an IND for resistant cancer treatment.
How much funding has Thryv Therapeutics raised?
Thryv Therapeutics has raised $5.0M across 2 rounds on record.
When did Thryv Therapeutics last raise funding?
Thryv Therapeutics' most recent funding round on record was announced in Sep 2025. The amount was not disclosed.
Who founded Thryv Therapeutics?
FundedIQ lists Daphne Doucet (Founder) at Thryv Therapeutics.
Where is Thryv Therapeutics headquartered?
Thryv Therapeutics is based in Laval, Quebec, Canada.
How many employees does Thryv Therapeutics have?
Thryv Therapeutics is in the 11-50 employee band.
About FundedIQ's Thryv Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Thryv Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.